The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $0.75 for the day, down -3.86% from the previous closing price of $0.78. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.30 and its Current Ratio is at 13.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 10 ’24 when Finn Jonathan bought 25,000 shares for $1.77 per share. The transaction valued at 44,250 led to the insider holds 25,000 shares of the business.
Stock Price History:
Over the past 52 weeks, ATOS has reached a high of $2.31, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -17.29%, while the 200-Day Moving Average is calculated to be -39.37%.
Shares Statistics:
A total of 125.80M shares are outstanding, with a floating share count of 125.78M. Insiders hold about 0.02% of the company’s shares, while institutions hold 28.40% stake in the company.
